PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 738 participants.
Also called NCT04089059
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 738 participants
- Sponsor
- Endotronix, Inc.
- Registry
-
NCT04089059
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Belgium, Ireland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04089059. Allocation not applicable; no masking; primary purpose diagnostic. Start 2020-01-10 (actual); primary completion 2028-04 (anticipated). Results posted on 2025-03-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
- Acronym
- PROACTIVE-HF
- Condition
- Heart Failure NYHA Class III
- Intervention (Device)
- Cordella™ Pulmonary Artery Sensor System
- Lead sponsor
- Endotronix, Inc.
Record details
- Record id
cardio:ct-nct04089059- Content hash
a2f9720a859dddce98612cbd8fdf41a5874c904601a73944c520b55fae9f3d30